We are delighted to announce the commencement of two clinical trials on chronic pelvic pain syndrome (CPPS)/chronic prostatitis (CP) in Japan at two prestigious sites, under the esteemed guidance of Dr. Akira Tsujimura, Professor at the Department of Urology, Juntendo University Urayasu Hospital. Dr. Tsujimura is a renowned expert in the fields of sexual medicine, male infertility, testosterone, and prostate health, with decades of professional experience and memberships in global associations such as the American Urological Association and the International Society for Sexual Medicine. Trial Sites:📍 D Clinic Tokyo, led by Dr. Taro Koyama📍 D Clinic Osaka, led by Dr. Yoshihiro Yasuda We are incredibly optimistic about the outcomes of these trials and deeply value the opportunity to collaborate with Dr. Tsujimura and his team. This marks a significant milestone, and we are excited to share updates on the progress as the trials move forward. Thank you for supporting this incredible journey toward innovation and better healthcare!
Day: 3 December 2024
Milestone Achievement: 43 Million Shocks Delivered!
We’re thrilled to announce that one of our Renova systems for treating ED with Li-shockwaves in China has now surpassed an incredible 43 MILLION shockwaves since its installation in July 2020! 🚀 This remarkable achievement reflects over 4 years of continuous and reliable operation at Jianguo Traditional Chinese Medicine’s Hospital of Wuxi, a private hospital specializing in the andrological field, located in Wuxi City, Jiangsu Province. The system was supplied through our sub-dealer in Taiyuan. This milestone underscores the durability of our technology, the resilience of our transducers, and our unwavering commitment to delivering consistent, high-quality patient care. Key performance indicators, such as shockwave pressure and water circulation, continue to operate at peak levels, ensuring optimal outcomes for over 2,000 patients treated. We take pride in this success, which exemplifies the reliability of our systems and our dedication to innovation and excellence in healthcare technology.